Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea Health Ministry's New Pricing Policy Draws Ire From Local Generics Makers

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs' new pricing policy, currently being re-crafted, is drawing criticism from the country's domestic generic drug makers because part of the new policy is calling for much lower prices on generics and original products coming off patent protection

You may also be interested in...



South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig

To ramp up pharmaceutical sales, the company may have to overcome some considerable challenges directly linked to the country's increasingly indebted health care system.

South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig

To ramp up pharmaceutical sales, the company may have to overcome some considerable challenges directly linked to the country's increasingly indebted health care system.

South Korea Drug Pricing Strategies Needed Now, Says Merck KGaA's South Korean President Juergen Koenig

HONG KONG - South Korea needs to clarify drug pricing regulations and speed up its decision-making process for new products if it hopes to attract, or even maintain, investment in the R&D pharmaceutical space

Related Content

UsernamePublicRestriction

Register

SC070030

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel